Henry Schein HSIC is well positioned to gain from its extensive global foothold and diverse channel mix. Yet, global economic ...

Dental and medical professionals who may experience operational, logistical, or financial issues are encouraged to call 800-999-9729 ...

Shares of Henry Schein, Inc. (NASDAQ:HSIC – Get Free Report) have been assigned an average recommendation of “Moderate Buy” ...

Strong Potential of Henry Schein One: Henry Schein’s dental software business, Henry Schein One, has been progressing well, driving robust gains across its core products, including practice ...

As previously reported, BofA analyst Allen Lutz upgraded Henry Schein (HSIC) to Buy from Underperform with a price target of $84, up from $69, ...

Henry Schein is a leading global distributor of health-care products and services primarily to office-based dental and medical practitioners. The company operates through two segments that offer ...

BofA sees 2025 challenges for healthcare tech and distributors but upgrades Cardinal Health and Henry Schein, highlighting ...

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that ...

Valued at a market cap of $8.8 billion, Henry Schein, Inc. (HSIC) provides healthcare products and services to dental practitioners, laboratories, physician practices, ambulatory surgery centers ...